Heal Capital: Europe's leading HealthTech VC fund, backed by German insurers, investing €100m in mission-driven startups.
Location
Berlin, DE
Founded
2019
Heal Capital is a leading European venture capital fund focused on HealthTech, with a total investment volume of €100 million. The firm primarily invests in mission-driven startups at the seed stage, providing both capital and specialized expertise to accelerate market access within the healthcare system. Heal Capital is backed by German private health insurers, underscoring its strong industry connections and commitment to integrated HealthTech solutions.
Notable portfolio companies include Moray Medical, which has raised $5.7 million, and Sanvivo, with $1 million in funding. Heal Capital's investment philosophy centers on supporting innovative HealthTech startups that can significantly impact healthcare delivery and patient outcomes. The firm offers unique value-add services, leveraging its deep industry knowledge and network to help portfolio companies navigate the complex healthcare landscape. Key partners and decision-makers bring extensive experience from both the healthcare and investment sectors, ensuring strategic guidance and support for their investments.
Heal Capital - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies3
Current Portfolio Count3
Top Investment Stages
Seed3 (100.0%)
Stage Mix
Seed 100%
Concentration shown as share of disclosed investments by stage.
